Robin Ryther

1.2k total citations
19 papers, 850 citations indexed

About

Robin Ryther is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Robin Ryther has authored 19 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Cognitive Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Robin Ryther's work include Genetics and Neurodevelopmental Disorders (11 papers), Autism Spectrum Disorder Research (9 papers) and Family and Disability Support Research (5 papers). Robin Ryther is often cited by papers focused on Genetics and Neurodevelopmental Disorders (11 papers), Autism Spectrum Disorder Research (9 papers) and Family and Disability Support Research (5 papers). Robin Ryther collaborates with scholars based in United States, Denmark and United Kingdom. Robin Ryther's co-authors include James G. Patton, Alex S. Flynt, Jennifer Phillips, Michael Wong, John A. Phillips, James S. Sutcliffe, Jonathan L. Haines, Bassel Abou‐Khalil, R. Desai and Alfred L. George and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Endocrinology.

In The Last Decade

Robin Ryther

18 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Ryther United States 12 463 336 238 163 102 19 850
Takeo Kato Japan 17 741 1.6× 254 0.8× 149 0.6× 51 0.3× 68 0.7× 60 1.3k
Elisabetta Bolognesi Italy 21 257 0.6× 207 0.6× 96 0.4× 202 1.2× 72 0.7× 50 973
Matthew Halvorsen United States 18 610 1.3× 271 0.8× 44 0.2× 90 0.6× 49 0.5× 38 999
Louise R. Simard Canada 26 1.7k 3.8× 263 0.8× 67 0.3× 44 0.3× 78 0.8× 55 2.3k
Tomonari Awaya Japan 17 691 1.5× 180 0.5× 50 0.2× 80 0.5× 60 0.6× 55 1.1k
Michele Salemi Italy 16 382 0.8× 119 0.4× 36 0.2× 49 0.3× 46 0.5× 76 804
José Pedro Vieira Portugal 15 228 0.5× 250 0.7× 131 0.6× 179 1.1× 108 1.1× 48 702
Ivon Cuscó Spain 23 989 2.1× 460 1.4× 31 0.1× 182 1.1× 46 0.5× 42 1.5k
William Hulme United States 10 293 0.6× 232 0.7× 54 0.2× 170 1.0× 101 1.0× 14 927
Chris Ramsey United States 9 120 0.3× 255 0.8× 140 0.6× 86 0.5× 58 0.6× 11 1.2k

Countries citing papers authored by Robin Ryther

Since Specialization
Citations

This map shows the geographic impact of Robin Ryther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Ryther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Ryther more than expected).

Fields of papers citing papers by Robin Ryther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Ryther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Ryther. The network helps show where Robin Ryther may publish in the future.

Co-authorship network of co-authors of Robin Ryther

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Ryther. A scholar is included among the top collaborators of Robin Ryther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Ryther. Robin Ryther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Percy, Alan K., Robin Ryther, Eric D. Marsh, et al.. (2025). Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2–4 years with Rett syndrome. Med. 6(6). 100608–100608.
2.
Percy, Alan K., Robin Ryther, Eric D. Marsh, et al.. (2024). Trofinetide for the Treatment of Girls Aged Two to Four Years with Rett Syndrome: Final Results from the Open-label DAFFODIL Study (S37.003). Neurology. 102(7_supplement_1). 6 indexed citations
3.
Neul, Jeffrey L., Tim A. Benke, Eric D. Marsh, et al.. (2023). Distribution of hand function by age in individuals with Rett syndrome. SHILAP Revista de lepidopterología. 1(3). 228–238. 5 indexed citations
4.
Percy, Alan K., Robin Ryther, Eric D. Marsh, et al.. (2023). Trofinetide for the treatment of Rett syndrome: an open-label study in girls 2 to 4 years of age (P13-9.005). Neurology. 100(17_supplement_2). 4 indexed citations
5.
Motil, Kathleen J., Suzanne Geerts, Fran Annese, et al.. (2022). Anthropometric Measures Correspond with Functional Motor Outcomes in Females with Rett Syndrome. The Journal of Pediatrics. 244. 169–177.e3. 7 indexed citations
6.
Fang, Xiaolan, Kameryn M. Butler, Fatima Abidi, et al.. (2022). Analysis of X‐inactivation status in a Rett syndrome natural history study cohort. Molecular Genetics & Genomic Medicine. 10(5). e1917–e1917. 13 indexed citations
7.
Fang, Xiaolan, Kameryn M. Butler, Fatima Abidi, et al.. (2021). Analysis of X-inactivation status in a Rett syndrome natural history study cohort. Molecular Genetics and Metabolism. 132. S239–S239. 2 indexed citations
8.
Peters, Sarika U., Cary Fu, Eric D. Marsh, et al.. (2020). Phenotypic features in MECP2 duplication syndrome: Effects of age. American Journal of Medical Genetics Part A. 185(2). 362–369. 15 indexed citations
9.
Raspa, Melissa, Carla Bann, Tim A. Benke, et al.. (2020). A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials. American Journal on Intellectual and Developmental Disabilities. 125(6). 493–509. 28 indexed citations
10.
Peters, Sarika U., Cary Fu, Bernhard Suter, et al.. (2019). Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome. Clinical Genetics. 95(5). 575–581. 38 indexed citations
11.
Neul, Jeffrey L., Tim A. Benke, Eric D. Marsh, et al.. (2018). The array of clinical phenotypes of males with mutations in Methyl‐CpG binding protein 2. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 180(1). 55–67. 66 indexed citations
12.
Ryther, Robin, Mary Bertrand, Donna B. Jeffe, et al.. (2014). Developing the Pediatric Refractory Epilepsy Questionnaire: A pilot study. Epilepsy & Behavior. 37. 26–31. 2 indexed citations
13.
Larson, Anna M., Robin Ryther, Mélanie Jennesson, et al.. (2012). Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia. 53(7). 1162–1169. 95 indexed citations
14.
Ryther, Robin & Michael Wong. (2012). Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy. Current Neurology and Neuroscience Reports. 12(4). 410–418. 48 indexed citations
15.
Shariat, Nikki W., Robin Ryther, John A. Phillips, Iain C. A. F. Robinson, & James G. Patton. (2007). Rescue of Pituitary Function in a Mouse Model of Isolated Growth Hormone Deficiency Type II by RNA Interference. Endocrinology. 149(2). 580–586. 14 indexed citations
16.
Ryther, Robin, Alex S. Flynt, Jennifer Phillips, & James G. Patton. (2004). siRNA therapeutics: big potential from small RNAs. Gene Therapy. 12(1). 5–11. 252 indexed citations
17.
Ryther, Robin, Alex S. Flynt, Bryan Harris, John A. Phillips, & James G. Patton. (2004). GH1 Splicing Is Regulated by Multiple Enhancers Whose Mutation Produces a Dominant-Negative GH Isoform That Can Be Degraded by Allele-Specific Small Interfering RNA (siRNA). Endocrinology. 145(6). 2988–2996. 50 indexed citations
18.
Ryther, Robin, Lindsay McGuinness, John A. Phillips, et al.. (2003). Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II. Human Genetics. 113(2). 140–148. 48 indexed citations
19.
Abou‐Khalil, Bassel, Qing Ge, R. Desai, et al.. (2001). Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology. 57(12). 2265–2272. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Kato Breakdown of academic impact, for papers by Elisabetta Bolognesi Breakdown of academic impact, for papers by Matthew Halvorsen Breakdown of academic impact, for papers by Louise R. Simard Breakdown of academic impact, for papers by Tomonari Awaya Breakdown of academic impact, for papers by Michele Salemi Breakdown of academic impact, for papers by José Pedro Vieira Breakdown of academic impact, for papers by Ivon Cuscó Breakdown of academic impact, for papers by William Hulme Breakdown of academic impact, for papers by Chris Ramsey
Rankless by CCL
2026